RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

Core Viewpoint - RxSight, Inc. will report its financial results for Q3 2025 on November 5, 2025, with a conference call scheduled for 1:30 p.m. Pacific Time [1] Company Overview - RxSight, Inc. specializes in ophthalmic medical devices aimed at providing customized vision for patients post-cataract surgery [3] - The company offers the RxSight® Light Adjustable Lens system, which is the first and only commercially available intraocular lens technology that can be adjusted after surgery [3] - This technology allows doctors to tailor and enhance the quality of vision for patients following cataract procedures [3] Conference Call Details - The conference call to discuss the financial results can be accessed by dialing (800) 715-9871 or (646) 307-1963, with the conference code: 6619966 [2] - The call will also be available in listen-only mode via the company's investor relations website [2] - An archived recording of the call will be accessible shortly after its conclusion [2]